CYAD

Celyad Oncology SA American Depositary Shares
CYAD

Overview Fund Activity
Delisted

CYAD was delisted on the 18th of May, 2023.

Back to rankings

2 hedge funds and large institutions have $9.27K invested in Celyad Oncology SA American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-6
Holders Change %
-75%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BBA
Baader Bank Aktiengesellschaft
Germany
+$5.67K
2
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$3.6K

Top Sellers

1
FIG
Fortress Investment Group
New York
-$6.23M
2
KI
Kapitalo Investimentos
Brazil
-$29.8K
3
Citadel Advisors
Citadel Advisors
Florida
-$15.3K
4
TSS
Two Sigma Securities
New York
-$10.6K
5
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$3.09K
Name Holding Trade Value Shares
Change 		Shares
Change %
BBA
1
Baader Bank Aktiengesellschaft
Germany
$5.67K +$5.67K +18,277 New
RhumbLine Advisers
2
RhumbLine Advisers
Massachusetts
$3.6K +$3.6K +9,000 New
FIG
3
Fortress Investment Group
New York
– -$6.23M -6,500,000 Closed
KI
4
Kapitalo Investimentos
Brazil
– -$29.8K -31,326 Closed
Citadel Advisors
5
Citadel Advisors
Florida
– -$15.3K -16,285 Closed
TSS
6
Two Sigma Securities
New York
– -$10.6K -11,032 Closed
National Bank of Canada
7
National Bank of Canada
Quebec, Canada
– -$3.09K -3,400 Closed
UBS Group
8
UBS Group
Switzerland
– -$2.04K -2,124 Closed
Wells Fargo
9
Wells Fargo
California
– -$546 -570 Closed
Morgan Stanley
10
Morgan Stanley
New York
– -$96 -100 Closed